(Q46229231)

20 December 2017

title

Anti-inflammatory effect of erythropoietin pretreatment on cardiomyocytes with hypoxia/reoxygenation injury and the possible mechanism (English)

1 reference

20 December 2017

1 reference

1 reference

Chuan Qin

1

1 reference

20 December 2017

Ying-Bin Xiao

2

1 reference

20 December 2017

Qian-Jin Zhong

3

1 reference

20 December 2017

Lin Chen

4

1 reference

20 December 2017

Xue-Feng Wang

5

1 reference

20 December 2017

publication date

1 December 2008

1 reference

20 December 2017

Chinese Journal of Traumatology

published in

1 reference

20 December 2017

volume

11

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

352-358

1 reference

20 December 2017

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

A risk-benefit assessment of epoetin in the management of anaemia associated with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Erythropoietin protects against ischaemic acute renal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Potential for protection and repair following injury to the developing brain: a role for erythropoietin?

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

ISSLS prize winner: Erythropoietin inhibits spinal neuronal apoptosis and pain following nerve root crush

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Erythropoietin and VEGF exhibit equal angiogenic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps.

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

A novel protective effect of erythropoietin in the infarcted heart

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Effects of erythropoietin on cardiac remodeling after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Chronic erythropoietin treatment limits infarct-size in the myocardium in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Cardioprotective effects of recombinant human erythropoietin in rats with experimental autoimmune myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1008-1275%2808%2960071-1

7 January 2021

10.1016/S1008-1275(08)60071-1

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017